Botanical Description
Feverfew (Tanacetum parthenium, syn. Chrysanthemum parthenium) is a bushy, aromatic perennial in the Asteraceae family, native to southeastern Europe and now naturalized across the temperate world. Plants grow 12–24 inches tall with deeply lobed, bright yellowish-green leaves that have a distinctive bitter, citrus-like aroma. Small, daisy-like flower heads with white ray petals and raised yellow centers appear in profuse clusters throughout summer.
The plant self-seeds freely and can become a persistent garden volunteer—an attribute that has made it a fixture of cottage gardens and herb borders for centuries. Its strong aroma and bitter taste deter most herbivorous insects, making it one of the most pest-free herbs in cultivation.
The Raw Leaf Tradition
The traditional method of using feverfew for migraines is remarkably simple and has persisted unchanged for centuries: chew 1–3 fresh leaves daily as a preventive measure. The practice was popularized in the 1970s when a Welsh doctor’s wife, a chronic migraine sufferer, began chewing feverfew leaves on the advice of a coal miner who had used the same remedy. Her dramatic improvement caught the attention of the medical community and triggered the first clinical investigations.
Growing Requirements
| Parameter | Range / Tolerance |
|---|---|
| USDA Hardiness Zones | 5–10 |
| Light | Full sun to partial shade |
| Soil | Average, well-drained; tolerates poor soil; pH 6.0–6.7 |
| Moisture | Low to moderate; drought-tolerant once established |
| Propagation | Seed (easy; surface sow), cuttings, or division |
| Spacing | 12–15 inches |
Phytochemistry
| Compound Class | Key Members |
|---|---|
| Sesquiterpene Lactones | Parthenolide (primary active; 0.2–0.5% of dry leaf weight) |
| Flavonoids | Tanetin (lipophilic flavonol; anti-inflammatory) |
| Volatile Oil | Camphor, chrysanthenyl acetate, borneol |
| Melatonin | Present in significant quantities; may contribute to migraine prophylaxis |
Parthenolide is thought to prevent migraines through multiple mechanisms: inhibiting serotonin release from platelets, reducing prostaglandin synthesis, blocking NF-kB inflammatory pathways, and preventing smooth muscle spasms in cerebral blood vessels. This multi-target approach may explain why feverfew is more effective as a prophylactic (preventive) than as an acute treatment.
Clinical Research
- Migraine prevention: A landmark 1988 RCT in The Lancet demonstrated a 24% reduction in migraine frequency and significantly reduced nausea and vomiting in feverfew-treated patients compared to placebo. Subsequent trials have produced mixed but generally supportive results.
- Cochrane review: The 2015 Cochrane analysis concluded that feverfew is “likely to be effective” for migraine prevention based on available evidence, while noting study heterogeneity and the need for larger, more standardized trials.
- Dose-response: Clinical benefit appears to require a minimum of 0.2% parthenolide content in the dried leaf, taken consistently for at least 4–6 weeks before full prophylactic effect is established.
Precautions
- Mouth ulcers: Chewing fresh leaves can cause mouth sores and lip swelling in ~10% of users. Capsules or dried-leaf preparations avoid this issue.
- Rebound headaches: Abrupt discontinuation after long-term use may trigger rebound migraines. Taper gradually.
- Pregnancy: Contraindicated; parthenolide may stimulate uterine contractions.
- Blood thinning: May inhibit platelet aggregation; avoid with anticoagulants.
- Asteraceae allergy: Cross-reactivity possible.
References
- Murphy et al., The Lancet (1988) — landmark migraine RCT
- Pittler & Ernst, Cochrane Database of Systematic Reviews (2004, updated 2015) — feverfew for migraine
- Pareek et al., Journal of Ethnopharmacology (2011) — feverfew comprehensive review
- European Medicines Agency, Herbal Monograph on Tanacetum parthenium
- British Herbal Pharmacopoeia — feverfew monograph